These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 16121689)
1. Therapy and prophylaxis of Ebola virus infections. Feldmann H; Jones SM; Schnittler HJ; Geisbert T Curr Opin Investig Drugs; 2005 Aug; 6(8):823-30. PubMed ID: 16121689 [TBL] [Abstract][Full Text] [Related]
2. Towards a vaccine against Ebola virus. Geisbert TW; Jahrling PB Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361 [TBL] [Abstract][Full Text] [Related]
3. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus. Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083 [TBL] [Abstract][Full Text] [Related]
5. Ebola virus: from discovery to vaccine. Feldmann H; Jones S; Klenk HD; Schnittler HJ Nat Rev Immunol; 2003 Aug; 3(8):677-85. PubMed ID: 12974482 [TBL] [Abstract][Full Text] [Related]
6. Development of treatment strategies to combat Ebola and Marburg viruses. Paragas J; Geisbert TW Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210 [TBL] [Abstract][Full Text] [Related]
7. Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995. Kerstiëns B; Matthys F J Infect Dis; 1999 Feb; 179 Suppl 1():S263-7. PubMed ID: 9988193 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Bausch DG; Sprecher AG; Jeffs B; Boumandouki P Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927 [TBL] [Abstract][Full Text] [Related]
10. [Ebola virus and yellow fever: lessons to learn from the epidemics]. Baudon D Med Trop (Mars); 1995; 55(2):133-4. PubMed ID: 7564992 [No Abstract] [Full Text] [Related]
11. A DNA vaccine for the prevention of Ebola virus infection. Dery M; Bausch DG Curr Opin Mol Ther; 2008 Jun; 10(3):285-93. PubMed ID: 18535936 [TBL] [Abstract][Full Text] [Related]
13. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. Roels TH; Bloom AS; Buffington J; Muhungu GL; Mac Kenzie WR; Khan AS; Ndambi R; Noah DL; Rolka HR; Peters CJ; Ksiazek TG J Infect Dis; 1999 Feb; 179 Suppl 1():S92-7. PubMed ID: 9988170 [TBL] [Abstract][Full Text] [Related]
14. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Geisbert TW; Hensley LE Expert Rev Mol Med; 2004 Sep; 6(20):1-24. PubMed ID: 15383160 [TBL] [Abstract][Full Text] [Related]
15. The 1995 Kikwit Ebola outbreak--model of virus properties on system capacity and function: a lesson for future viral epidemics. Hall RC; Hall RC Am J Disaster Med; 2007; 2(5):270-6. PubMed ID: 18491842 [TBL] [Abstract][Full Text] [Related]
16. Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection. Lucht A; Formenty P; Feldmann H; Gotz M; Leroy E; Bataboukila P; Grolla A; Feldmann F; Wittmann T; Campbell P; Atsangandoko C; Boumandoki P; Finke EJ; Miethe P; Becker S; Grunow R J Infect Dis; 2007 Nov; 196 Suppl 2():S184-92. PubMed ID: 17940948 [TBL] [Abstract][Full Text] [Related]
17. Ebola hemorrhagic fever: lessons from Kikwit, Democratic Republic of the Congo. Heymann DL; Barakamfitiye D; Szczeniowski M; Muyembe-Tamfum JJ; Bele O; Rodier G J Infect Dis; 1999 Feb; 179 Suppl 1():S283-6. PubMed ID: 9988197 [TBL] [Abstract][Full Text] [Related]
18. Ebola hemorrhagic fever in the era of bioterrorism. Polesky A; Bhatia G Semin Respir Infect; 2003 Sep; 18(3):206-15. PubMed ID: 14505282 [TBL] [Abstract][Full Text] [Related]